IP Library Granted Patent US 12,398,409
Granted Patent B2
US 12,398,409 · App. 18/330,457 · Granted Aug 26, 2025

Yeast cells genetically modified for downregulation of pyruvate decarboxylase activity and FBP-sensitive pyruvate kinase

Inventors: Anastasia Krivoruchko (Gothenburg, SE); Jens Nielsen (Hellerup, DK); Florian David (Gothenburg, SE); Tao Yu (Shenzhen, CN)
Assignee: Melt&Marble AB
C12P7/6409C12N1/16C12N9/93C12Y604/01001C12Y604/01002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,398,409
App. No.
18/330,457
Granted
Aug 26, 2025
Kind
B2
Abstract

A fungal cell capable of producing high levels of fatty acids and fatty acid-derived products comprises at least one modification to the endogenous fatty acid metabolism.

Claims (26)

1. A yeast cell, wherein

pyruvate decarboxylase activity in said yeast cell is downregulated by the deletion of at least one gene selected from the group consisting of PDC1, PDC5 and PDC6; and

said yeast cell is further genetically modified for

downregulation of an endogenous fructose-1,6-bisphosphate (FBP)-sensitive pyruvate kinase PYK1; and/or

overexpression of an endogenous fructose-1,6-bisphosphate (FBP)-insensitive pyruvate kinase PYK2, wherein

said yeast cell has reduced ethanol formation compared to an unmodified yeast cell by said deletion of at least one gene selected from the group consisting of PDC1, PDC5 and PDC6; and

said yeast cell is able to grow on glucose as a carbon source by said downregulation of said endogenous PYK1 and/or said overexpression of said endogenous PYK2.

2. The yeast cell according to claim 1 , wherein said yeast cell is genetically modified for overexpression of an endogenous acetyl-CoA carboxylase.

3. The yeast cell according to claim 1 , wherein said yeast cell is genetically modified for overexpression of an endogenous pyruvate carboxylase.

4. The yeast cell according to claim 1 , wherein said yeast cell is further genetically modified for overexpression of at least one protein selected from the group consisting of a mitochondrial pyruvate carrier, a citrate synthase and a citrate and oxoglutarate carrier protein.

5. The yeast cell according to claim 4 , wherein said mitochondrial pyruvate carrier is selected from the group consisting of MPC1 and MPC3.

6. The yeast cell according to claim 4 , wherein said citrate synthase is selected from the group consisting of Rhodosporidium toruloides citrate synthase RtCIT1 and Saccharomyces cerevisiae citrate synthase ScCIT1.

7. The yeast cell according to claim 4 , wherein said citrate and oxoglutarate carrier protein is YHM2.

8. The yeast cell according to claim 1 , wherein said yeast cell is genetically modified for overexpression of a gene selected from the group consisting of MPP6, ACP1, EPT1, FAA1, GEP4, GGA2, IDP3, INP54, LPP1, MCR1, ORMI, RTC3, SPO7, TGL1 and YFT2.

9. The yeast cell according to claim 8 , wherein said yeast cell is genetically modified for overexpression of GGA2.

10. The yeast cell according to claim 1 , wherein said yeast cell is a yeast cell selected from the group consisting of Saccharomyces, Kluyveromyces, Zygosaccharomyces, Candida, Hansenula, Torulopsis, Kloeckera, Pichia, Schizosaccharomyces , Trigonopsis, Brettanomyces, Debaromyces, Nadsonia, Lipomyces, Cryptococcus, Aureobasidium, Trichosporon, Lipomyces, Rhodotorula, Yarrowia , Rhodosporidium, Phaffia, Schwanniomyces, Aspergillus , and Ashbya.

11. The yeast cell according to claim 10 , wherein said yeast cell is a yeast cell selected from the group consisting of Saccharomyces cerevisiae, Pichia pastoris, Ashbya gossypii, Saccharomyces boulardii, Zygosaccharomyces bailii, Kluyveromyces lactis , Rhodosporidium toruloides and Yarrowia lipolytica.

12. A method for producing a fatty acid comprising:

culturing a yeast cell according to claim 1 in a culture medium and in culture conditions suitable for production of said fatty acid by said yeast cell, and

collecting said fatty acid from said culture medium and/or said yeast cell,

wherein the yeast cell according to claim 1 is genetically modified for overexpression of an endogenous acetyl-CoA carboxylase and genetically modified for overexpression of an endogenous pyruvate carboxylase.

13. A method for producing a fatty acid derived-product comprising:

culturing a yeast cell according claim 1 in a culture medium and in culture conditions suitable for production of said fatty acid-derived product by said yeast cell; and

collecting said fatty acid-derived product from said culture medium and/or said yeast cell,

wherein said fatty acid-derived product is selected from the group consisting of a hydrocarbon, a triacylglyceride, a phospholipid, a lactone, a fatty alcohol, a fatty aldehyde, a fatty acid ester, and a mixture thereof, and

wherein the yeast cell according to claim 1 is genetically modified for overexpression of an endogenous acetyl-CoA carboxylase and genetically modified for overexpression of an endogenous pyruvate carboxylase.

Continuity (3)
Continuation 16830854 · Mar 26, 2020
Provisional Application 62824398 · Mar 27, 2019
Related Publication 20230313242A1 · Oct 5, 2023
References Cited (22)
US 10533198B2 · Nielsen et al. · 2020 [cited by applicant]
US 11162119B2 · Nielsen et al. · 2021 [cited by applicant]
US 11692209B2 · Krivoruchko · 2023 [cited by examiner]
US 20040214306A1 · Bloom · 2004 [cited by examiner]
US 20110125118A1 · Lynch · 2011 [cited by examiner]
US 20110223641A1 · Stephanopoulos · 2011 [cited by examiner]
US 20160215308A1 · Runguphan · 2016 [cited by examiner]
US 20160237441A1 · Nielsen · 2016 [cited by examiner]
CN 107164254A · 2017 [cited by applicant]
WO 2014016328A1 · 2014 [cited by applicant]
WO 2016159869A1 · 2016 [cited by applicant]
WO 2018192572A1 · 2018 [cited by applicant]
Pfleger, Brian F. et al., Metabolic engineering strategies for microbial synthesis of oleochemicals, Metabolic Engineering, vol. 29, pp. 1-50 (2015). [cited by applicant]
Yu, Tao et al., Reprogramming Yeast Metabolism from Alcoholic Fermentation to Lipogenesis, Cell, vol. 174, pp. 1549-1558 (Sep. 6, 2018). [cited by applicant]
Singh, Raushan Kumar et al., Protein Engineering Approaches in the Post-Genomic Era, Current Protein and Peptide Science, vol. 18, pp. 1-11 (2017). [cited by applicant]
Jones, Krstala et al., De novo biosynthetic pathways: rational design of microbial chemical factories, Current Opinion In Biotechnology, vol. 19, pp. 468-474 (2008). [cited by applicant]
Chica Roberto A et al., Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design, Current Opinion in Biotechnology, vol. 16, pp. 378-384 (2005). [cited by applicant]
Kizer, Lance et al., Application of Functional Genomics to Pathway Optimization for Increased Isoprenoid Production, Applied and Environmental Microbiology, vol. 74, No. 10, pp. 3229-3241 (2008). [cited by applicant]
Accession Q00955, Apr. 1, 1993. [cited by applicant]
Accession P11154. Jul. 1, 1989. [cited by applicant]
Accession Q5BAJ4 Apr. 26, 2005. [cited by applicant]
Accession P38225 Oct. 1, 1994. [cited by applicant]